VEGFR2 Targeted Antibody Fused With MICA Stimulates NKG2D Mediated Immunosurveillance and Exhibits Potent Anti-Tumor Activity Against Breast Cancer

Oncotarget - United States
doi 10.18632/oncotarget.7501
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Nanoparticulate Vacuolar ATPase Blocker Exhibits Potent Host-Targeted Antiviral Activity Against Feline Coronavirus

Scientific Reports
Multidisciplinary
2017English

The Anti-erbB3 Antibody MM-121/SAR256212 in Combination With Trastuzumab Exerts Potent Antitumor Activity Against Trastuzumab-Resistant Breast Cancer Cells

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2013English

90y-Labeled Anti-Robo1 Monoclonal Antibody Exhibits Antitumor Activity Against Small Cell Lung Cancer Xenografts

PLoS ONE
Multidisciplinary
2015English

SKLB-287, a Novel Oral Multikinase Inhibitor of EGFR and VEGFR2, Exhibits Potent Antitumor Activity in LoVo Colorectal Tumor Model

Neoplasma
Cancer Research
2014English

A Novel Asymmetrical Anti-Her2/Cd3 Bispecific Antibody Exhibits Potent Cytotoxicity for HER2-positive Tumor Cells

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Discovery of Novel Potent VEGFR2 Inhibitors Exerting Significant Antiproliferative Activity Against Cancer Cell Lines

English

Synergistic Anti-Tumor Therapy by a Comb-Like Multifunctional Antibody Nanoarray With Exceptionally Potent Activity

Scientific Reports
Multidisciplinary
2015English

NK Cell-Mediated Anti-Leukemia Cytotoxicity Is Enhanced Using a NKG2D Ligand MICA and Anti-Cd20 SCFV Chimeric Protein

European Journal of Immunology
AllergyImmunology
2018English

Potent Antitumor Effect of Tumor Microenvironment-Targeted Oncolytic Adenovirus Against Desmoplastic Pancreatic Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy